Subject: Smoldering Myeloma

0:22:15

Smoldering myeloma: Who and when to treat?

0:02:43

Should we treat smoldering myeloma?

0:02:25

Q&A: What is Smoldering Myeloma and How Does it Progress? - 2024 Blood Cancer OncTalk

0:01:41

Mitigating smoldering myeloma progression risk

0:01:44

Smoldering myeloma: the challenges of 'watch and wait' versus early intervention

0:01:57

Rationale behind the watch and wait strategy in smoldering myeloma

0:02:18

Preventing progression: smoldering myeloma

0:02:12

Smoldering Multiple Myeloma (SMM) Basics #myeloma

0:01:59

Treating smoldering myeloma

0:03:31

What factors indicate smoldering multiple myeloma (SMM) will progress to active myeloma?

0:01:26

Identifying high-risk smoldering myeloma & minimizing treatment-related toxicity

0:02:56

Smoldering myeloma: highlights from ASH 2020

0:03:37

Smoldering myeloma: state of the art

0:01:04

Better understanding smoldering myeloma & improving the outcomes of patients with high-risk myeloma

0:01:28

Preventing progression of smoldering myeloma to multiple myeloma with anti-myeloma therapies

0:04:25

How to Treat High-Risk Smoldering Myeloma - 2024 Blood Cancer OncTalk

0:00:56

How do we define smoldering multiple myeloma?

0:02:44

A better understanding of smoldering myeloma to detect and prevent progression to multiple myeloma

0:01:29

To treat or not to treat smoldering myeloma & identifying patients at risk of progression to myeloma

0:02:52

Genomically aggressive or indolent smoldering myeloma and progression to multiple myeloma

0:02:10

Why should smoldering myeloma be treated early?

0:03:37

Irene Ghobrial: Preventing Progression from Smoldering to Symptomatic Myeloma

0:01:28

Risk stratification models for smoldering myeloma

0:03:48

The importance of treating patients with smoldering myeloma at high risk of progression to myeloma